In matter related to patent for its fully liquid Whole Cell Pertussis based fully liquid Hexavalent Vaccine, EasySix™Panacea Biotec announced that the company has instituted a suit before the Hon ble Delhi High Court seeking to restrain Sanofi Healthcare India from marketing a fully liquid hexavalent vaccine that would infringe Company s patent for its fully liquid Whole Cell Pertussis based fully liquid Hexavalent Vaccine, EasySix™.
Panacea Biotec s EasySix™ is a first of its kind Whole Cell Pertussis based fully liquid Hexavalent Vaccine which comes in a pre-filled syringe and is used to vaccinate against, Diphtheria, Tetanus, Whooping Cough, Hepatitis B, Haemophilus influenza type b and Inactivated Polio (DTwP-HepB-Hib-IPV). EasySix™ has been in the market since 2017.
Panacea Biotec Limited files suit against Sanofi Healthcare India Pvt Ltd equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.